Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Olfaction Disorders × Docosahexaenoic Acids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Obesity 4 Sarcopenia 3 Polycystic Ovary Syndrome 3 Neoplasms 3 Melanoma 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Malnutrition 2 Lymphoma, Follicular 2 Colorectal Neoplasms 2 Breast Carcinoma In Situ 2 Wound Infection 1 Weight Loss 1 Urinary Bladder Neoplasms 1 Surgical Wound Infection 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Psoriasis 1 Precancerous Conditions 1 Postoperative Complications 1 Polyps 1 Phagocyte Bactericidal Dysfunction 1 Pain 1 Paget's Disease, Mammary 1 Overweight 1 Osteoarthritis 1 Olfaction Disorders 1 Non-alcoholic Fatty Liver Disease 1

Interventions

Dronabinol 1 Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02529332 2018-08-21

Omega-3 Supplementation for Smell Dysfunction

Stanford University

Phase NA Completed

Olfaction Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡